Michael Morse, MD, MHS, FACP

Dr Morse has clinical expertise in management of gastrointestinal malignancies including colon, hepatobiliary, gastroesophageal, and pancreatic cancer. His research expertise includes the development of targeted therapies, including immunotherapies for cancer. He has published extensively on topics in cancer immunotherapy, targeted therapies, gastrointestinal malignancies, cancer vaccines, and liver tumors. He is the editor for Current Opinions in Biologic Therapies and has been principal investigator for several phase 1 and 2 clinical trials of cancer immunotherapy and therapies for gastrointestinal malignancies.